January 29, 2020 – New lawsuits are emerging as the public learns more about the alleged adverse effects of taking Zantac. Victims are now claiming it has caused stomach cancer, colon cancer, and even leukemia. These are in addition to the already-extensive list of illnesses being attributed to the drug.
Just a few months ago, the FDA warned the public that ranitidine, commonly sold under the name “Zantac,” has been found to contain unsafe levels of the carcinogen N-nitrosodimethylamine (NDMA). Since then, at least nine different companies that sell Zantac or a generic version of Zantac have voluntarily issued recalls for the drug. Interestingly, NDMA is no longer made in the US.
The FDA believes the NDMA found in Zantac is just a chemical impurity, but some plaintiffs are arguing that NDMA is actually formed in the body upon consumption. The latter suggests anybody could be injured by the drug, regardless of where or when they bought it.
Reference: TorHoerman Law, LLC, https://www.torhoermanlaw.com/pharmaceutical-products-case-types/zantac-lawsuit/